Replies to post #538302 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

Yes, TTF technology shouldn't be more expensive than blood pressure monitors or the common household microwave.

[biosectinvestor]

It has to drop. Optune's pricing is insane. I get that they have to recoup the costs of trials. So I don't hold that against them. But I don't see how they remain competitive.

[Hopeforthefuture3]

I agree the price is too high and should come down but currently there really are not any alternatives and they are approved and paid by most insurances so making hay while the sun shines. Perhaps if nwbo can get a marketing application actually submitted and approved then NVCR will have some competition.
Remember how the predictions for approval by now were common on this board but they have yet to even submit for approval(s). Seems EVERYTHING nwbo takes longer.
I may vote yes on increasing #shares but they first have to show they have a plan and a real timeline or I will just choose to not vote. Still hope they come thru and my guess of $7 by year end happens - not looking good so far.... Ou's guess of $0.35 seems a lot closer